The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CANDEL THERAPEUTICS INC | COM | 137404109 | 6,270 | 1,935,215 | SH | SOLE | 1,935,215 | 0 | 0 | ||
| CODEX DNA INC | COM | 192003101 | 17,719 | 9,844,130 | SH | SOLE | 9,844,130 | 0 | 0 | ||
| DICE THERAPEUTICS INC | COM | 23345J104 | 51,105 | 3,292,871 | SH | SOLE | 3,292,871 | 0 | 0 | ||
| ISOPLEXIS CORP | COM | 465005106 | 19,026 | 8,808,531 | SH | SOLE | 8,808,531 | 0 | 0 | ||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 10,873 | 4,214,498 | SH | SOLE | 4,214,498 | 0 | 0 | ||